Abstract Numbers 41 – 52
	41.) Mortality rates for Pancreaticoduodenectomy (Whipple's procedure) in a medium volume, public funded system.
	Jeremy Lipschitz, MD, Department of Surgery, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada.
	42.) The Outcome Of Surgical Management Of Pancreatic And Non Pancreatic Periampullary Tumors
	Madhava Pai, Paolo Limongelli, Andrew Healey, Stamp Gordon, Nagy Habib, Robin Williamson, Long Jiao, Hammersmith Hospital, Imperial College,, London, United Kingdom.
	43.) Feasibility and safety of pancreaticodudenectomy (the Whipple procedure) in a high volume community hospital.
	Roozbeh Rassadi, MD, Allison Vo, RN, Dhiresh Rohan Jeyarajah, MD, Dallas Methodist Medical Center, Dallas, TX.
	44.) Safety of pancreatic resection in the elderly
	Tsuneo Tanaka, MD, PhD, Naoki Kagawa, MD, PhD, Yasuhiro Matsugu, MD, PhD, Hideki Nakahara, MD, PhD, Hiroshima Prefectural Hospital, Hiroshima, Japan.
	45.) Community Hospital Outcomes of Whipple Procedure-For Regionalization of Care
	Pascal R Fuchshuber, MD, PhD, FACS, R Kwan, MD, C K Chang, MD, Kaiser Permanente Medical Center, Walnut Creek, CA; Department of Surgery, UCSF-East Bay, Oakland, CA.
	46.) Outcome following resection for pancreatic cancer based on surgeon experience: the long and short of it.
	Emmanuel E Zervos, MD, Nasreen A Vohra, MD, John E. Mullinax, Alexander S. Rosemurgy, MD, University of South Florida College of Medicine, Tampa, Fl 33612, FL.
	47.) Pancreatic Cancer Screening Program: Transcutaneous Ultrasound, Magnetic Resonance Imaging, and Psychosocial Measures
	Heidi Rothenmund, MS, Stephanie Wilson, MD, Masoom Haider, MD, Saumea Thayalan, Kara Semotiuk, MS, Spring Holter, MS, Poala Ardiles, Aletta Poll, MS, Steven Narod, MD, Susan Armel, MS, Anne Summers, MD, David Hogg, MD, Kate Butler, MS, Mary Jane Esplen, PhD, Steven Gallinger, MD, Mount Sinai Hospital, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; Women's College Hospital, Toronto, ON, Canada; Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada.
	48.) Treatment of Pancreatic Cancer In A Single Payer Network
	Ck Chang, MD, Js Choi, MD, Rc Liu, MD, Sk Liu, MD, T Rolle, MD, Pr Fuchshuber, MD, PhD, Kaiser Permanente, Walnut Creek, CA.
	49.) Practice variation and outcomes of pancreaticoduodenectomy: A population-based study
	Anand Govindarajan, MD, Jensen C. C. Tan, MD, Natalie G. Coburn, MD, MPH, Calvin H. L. Law, MD, MPH, University of Toronto, Toronto, ON, Canada.
	50.) Outcome of distal pancreatectomy for pancreatic adenocarcinoma
	Brian K Goh, Yu-meng Tan, MBBS, Peng-chung Cheow, MBBS, Yaw-fui Chung, MBBS, Pierce K. H. Chow, PhD, Wai-keong Wong, MBBS, London Lucien Ooi, MD, Singapore General Hospital, Singapore, Singapore.
	51.) Trends in the Epidemiology and Treatment of Pancreatic Cancer
	Anthony Chan, Ajith Siriwardena, Irvin Modlin, Mark Kidd, HPB Research Group, Manchester, United Kingdom; Gastric Pathobiology Research Group, New Haven, CT.
	52.) The Natural History of Resected Pancreatic Cancer Without Adjuvant Treatment
	Emmanuel Zervos, MD, Sam Al-saadi, MD, Jonathan Hernandez, MD, Desiree Villadolid, MPH, Amy Collins, Jennifer Cooper, Rachel Gillman, Nasreen Vohra, MD, Alexander Rosemurgy, MD, University of South Florida And Tampa General Hospital, Tampa, FL.
	Oral Posters (OP – 05) Liver I: Malignant
	Moderators: Sharon Weber, MD and Madison, WI and D. Rohan Jeyarajah, MD, Dallas, TX